Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
Port Delivery System With Ranibizumab Shows Positive Phase III Results in Neovascular Age-Related Macular Degeneration
12:00am, Wednesday, 27'th May 2020
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from the Phase III Archway study, evaluat
Baker Brothers Snap Up These 3 Small-Cap Biotech Stocks
02:43pm, Tuesday, 26'th May 2020
According to strategists from J.P. Morgan, who have been tracking biotech fund flows to gauge interest levels, the volatility exhibited over the last few years has persisted in 2020, but for now, flow
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
Why IVERIC bio (ISEE) Stock Might be a Great Pick
12:40pm, Thursday, 21'st May 2020
IVERIC bio (ISEE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Placenta Growth Factor Pipeline Review, H1 2020: Companies Involved in Therapeutics Development - ResearchAndMarkets.com
12:00am, Thursday, 21'st May 2020
The
The
Top Ranked Momentum Stocks to Buy for May 13th
01:49pm, Wednesday, 13'th May 2020
Top Ranked Momentum Stocks to Buy for May 13th
Top Ranked Momentum Stocks to Buy for May 12th
02:02pm, Tuesday, 12'th May 2020
Top Ranked Momentum Stocks to Buy for May 12th
Global Age-Related Macular Degeneration Market and Competitive Landscape 2020 - ResearchAndMarkets.com
12:00am, Tuesday, 12'th May 2020
The
Merger Arb Trade Review: AbbVie And Allergan
06:33pm, Monday, 11'th May 2020
In August 2019 I suggested a partially hedged trade of selling AbbVie and using the proceeds plus extra cash to buy Allergan for a 17% return on cash. Now that
New Strong Buy Stocks for May 11th
12:00pm, Monday, 11'th May 2020
New Strong Buy Stocks for May 11th
Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
12:00am, Monday, 11'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transform
Catalent, Inc. (CTLT) CEO John Chiminski on Q3 2020 Results - Earnings Call Transcript
03:20pm, Saturday, 09'th May 2020
Catalent, Inc. (NYSE:CTLT) Q3 2020 Earnings Conference Call May 5, 2020 08:15 ET Company Participants Paul Surdez - Vice President, Investor Relations John Chim
Gemini Therapeutics Appoints Marc E. Uknis, MD, FACS as Chief Medical Officer
12:00am, Thursday, 07'th May 2020
Gemini Therapeutics Appoints Marc E. Uknis, MD, FACS as Chief Medical Officer
